These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 25133684)

  • 1. Three-dimensional flash flow microreactor for scale-up production of monodisperse PEG-PLGA nanoparticles.
    Min KI; Im DJ; Lee HJ; Kim DP
    Lab Chip; 2014 Oct; 14(20):3987-92. PubMed ID: 25133684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PEG-PLGA copolymers: their structure and structure-influenced drug delivery applications.
    Zhang K; Tang X; Zhang J; Lu W; Lin X; Zhang Y; Tian B; Yang H; He H
    J Control Release; 2014 Jun; 183():77-86. PubMed ID: 24675377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel microfluidic synthesis of size-tunable polymeric nanoparticles using 3D flow focusing towards in vivo study.
    Lim JM; Bertrand N; Valencia PM; Rhee M; Langer R; Jon S; Farokhzad OC; Karnik R
    Nanomedicine; 2014 Feb; 10(2):401-9. PubMed ID: 23969105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol-loaded intranasally administered lectin functionalized poly(ethylene glycol)-block-poly(D,L)-lactic-co-glycolic acid (PEG-PLGA) nanoparticles for the treatment of schizophrenia.
    Piazza J; Hoare T; Molinaro L; Terpstra K; Bhandari J; Selvaganapathy PR; Gupta B; Mishra RK
    Eur J Pharm Biopharm; 2014 May; 87(1):30-9. PubMed ID: 24560967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of microfluidization parameters on the physical properties of PEG-PLGA nanoparticles prepared using high pressure microfluidization.
    Sani SN; Das NG; Das SK
    J Microencapsul; 2009 Sep; 26(6):556-61. PubMed ID: 18946802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study on MeO-PEG-PLGA-PEG-OMe nanoparticles as intravenous carriers.
    Duan Y; Xu J; Lin Y; Yu H; Gong T; Li Y; Zhang Z
    J Biomed Mater Res A; 2008 Nov; 87(2):515-23. PubMed ID: 18186066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells.
    Hu Y; Xie J; Tong YW; Wang CH
    J Control Release; 2007 Mar; 118(1):7-17. PubMed ID: 17241684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polymer grafting onto starch nanocrystals.
    Labet M; Thielemans W; Dufresne A
    Biomacromolecules; 2007 Sep; 8(9):2916-27. PubMed ID: 17718501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silicon microfluidic flow focusing devices for the production of size-controlled PLGA based drug loaded microparticles.
    Keohane K; Brennan D; Galvin P; Griffin BT
    Int J Pharm; 2014 Jun; 467(1-2):60-9. PubMed ID: 24680950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and characterization of folate anchored Saquinavir entrapped PLGA nanoparticles for anti-tumor activity.
    Singh R; Kesharwani P; Mehra NK; Singh S; Banerjee S; Jain NK
    Drug Dev Ind Pharm; 2015; 41(11):1888-901. PubMed ID: 25738812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microporous structure and drug release kinetics of polymeric nanoparticles.
    Sant S; Thommes M; Hildgen P
    Langmuir; 2008 Jan; 24(1):280-7. PubMed ID: 18052222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulating the surface poly(ethylene glycol) density of polymeric nanoparticles and evaluating its role in drug delivery in vivo.
    Du XJ; Wang JL; Liu WW; Yang JX; Sun CY; Sun R; Li HJ; Shen S; Luo YL; Ye XD; Zhu YH; Yang XZ; Wang J
    Biomaterials; 2015 Nov; 69():1-11. PubMed ID: 26275857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Magnetic conjugated polymer nanoparticles doped with a europium complex for biomedical imaging.
    Kemal E; Peters R; Bourke S; Fairclough S; Bergstrom-Mann P; Owen DM; Sandiford L; Dailey LA; Green M
    Photochem Photobiol Sci; 2018 Jun; 17(6):718-721. PubMed ID: 29780995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of the Polymer Architecture on the Structural and Biophysical Properties of PEG-PLA Nanoparticles.
    Rabanel JM; Faivre J; Tehrani SF; Lalloz A; Hildgen P; Banquy X
    ACS Appl Mater Interfaces; 2015 May; 7(19):10374-85. PubMed ID: 25909493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spatiotemporally programmable surface engineered nanoparticles for effective anticancer drug delivery.
    Ahmed A; Yu H; Han D; Rao J; Ding Y; Hu Y
    Macromol Biosci; 2014 Nov; 14(11):1652-62. PubMed ID: 25181029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-decorated PEG-PLGA nanoparticles with silica shells for capecitabine controlled and targeted delivery.
    Wei K; Peng X; Zou F
    Int J Pharm; 2014 Apr; 464(1-2):225-33. PubMed ID: 24463073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor alpha blocking peptide loaded PEG-PLGA nanoparticles: preparation and in vitro evaluation.
    Yang A; Yang L; Liu W; Li Z; Xu H; Yang X
    Int J Pharm; 2007 Feb; 331(1):123-32. PubMed ID: 17097246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PEG-PLA-PEG block copolymeric nanoparticles for oral immunization against hepatitis B.
    Jain AK; Goyal AK; Mishra N; Vaidya B; Mangal S; Vyas SP
    Int J Pharm; 2010 Mar; 387(1-2):253-62. PubMed ID: 20005936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate.
    Kim SH; Jeong JH; Chun KW; Park TG
    Langmuir; 2005 Sep; 21(19):8852-7. PubMed ID: 16142970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.